Generic Competition May Have Taken A Bite Out Of Lipitor
This article was originally published in The Pink Sheet Daily
Executive Summary
The statin’s sales got off to a sluggish start in the first quarter but Pfizer maintains the drug will reach its $13 bil. revenue target for the year.
You may also be interested in...
Zocor Hits A High Note In Last Quarter Before Generic Competition
Sales of the cholesterol-lowering drug increased 13% to $833 mil. during the first quarter.
Zocor Hits A High Note In Last Quarter Before Generic Competition
Sales of the cholesterol-lowering drug increased 13% to $833 mil. during the first quarter.
Exubera Adoption Not Recommended By U.K. Cost-Effectiveness Group
The National Institute for Health & Clinical Excellence says it needs more evidence on Pfizer’s inhaled insulin before it can recommend NHS coverage.